BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8305789)

  • 1. Therapeutic monitoring and pharmacist intervention in a Hansen's disease clinic.
    Piscitelli SC; Occhipinti DJ; Danziger LH; Hill C; West DP; Fischer JH
    Ann Pharmacother; 1993 Dec; 27(12):1526-31. PubMed ID: 8305789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a continual compliance monitoring program for dapsone in an outpatient Hansen's disease clinic.
    Fischer JH; West DP; Worobec SM
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):517-24. PubMed ID: 3819528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Hansen's disease.
    Alto WA
    Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Hansen's disease.
    Trautman JR
    Cutis; 1976 Jul; 18(1):62-5. PubMed ID: 1017285
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating Hansen's disease in developing countries.
    Jackson T
    West J Med; 1994 Mar; 160(3):278; author reply 279-80. PubMed ID: 8031394
    [No Abstract]   [Full Text] [Related]  

  • 6. Leprosy (Hansen's disease).
    Brazin SA
    Otolaryngol Clin North Am; 1982 Aug; 15(3):597-611. PubMed ID: 6752824
    [No Abstract]   [Full Text] [Related]  

  • 7. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of multidrug therapy on the treatment and control of leprosy.
    Gilbody JS
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of a dapsone compliance program in leprosy.
    Piscitelli SC; Danziger LH; Hill C; Slajchert AA; West DP; Fischer JH
    Int J Dermatol; 1993 Mar; 32(3):206-9. PubMed ID: 8444536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrogustometry in Hansen's disease (study of 225 cases).
    Rathi SS; Chaturvedi VN; Raizada RM; Jain SK
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):252-5. PubMed ID: 3722964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hansen's Disease and Rheumatoid Arthritis Crossover of Clinical Symptoms: A Case Series of 18 Patients in the United States.
    Labuda SM; Schieffelin JS; Shaffer JG; Stryjewska BM
    Am J Trop Med Hyg; 2017 Dec; 97(6):1726-1730. PubMed ID: 29141716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
    Medeiros S; Catorze MG; Vieira MR
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofazimine and dapsone compliance in leprosy.
    Ellard GA; Pannikar VK; Jesudasan K; Christian M
    Lepr Rev; 1988 Sep; 59(3):205-13. PubMed ID: 3200085
    [No Abstract]   [Full Text] [Related]  

  • 17. Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.
    Sheetal S; Arvind C
    Int J Rheum Dis; 2009 Apr; 12(1):64-9. PubMed ID: 20374320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
    Andrade VL; Marques AB; da Cunha LH; Avelleira JR
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):435-40. PubMed ID: 3655459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of tests for monitoring drug compliance of leprosy out-patients under multi-drug therapy.
    Balakrishnan S; Kumar A; Rao BR; Patro TP
    Indian J Lepr; 1986; 58(4):555-9. PubMed ID: 3572097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
    Legendre DP; Muzny CA; Swiatlo E
    Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.